Acme Generics Llp - Due diligence report

A 360° intelligence report on Acme Generics: trust score, financial health, credit view, compliance, directors, growth and distress signals …

2015-03-13 Chandigarh, Chandigarh Converted To Cmp And Dissolved
Share
Connect MCP
AG Acme Generics Llp
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Acme Generics — 360° Intelligence Report

Generated from MCA filings & public records
62/100
Trust Score
Moderate

Acme Generics is assessed as Moderate with a Trust Score of 62/100. Acme Generics is a limited liability partnership incorporated in 2015, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 27 Jul 2026 from the latest processed filings. Acme Generics Llp snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
62/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
23/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
75/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 75/100 Low Risk
  • No open charges - unencumbered balance sheet.
  • Profitable - internal accruals available.
  • Externally credit-rated (B+).

Charges position: 0 open (-) · 1 satisfied (15.00 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited1 48.0 cr
Compliance Score: 23/100 Caution Indicated
  • Company status is "Converted To Cmp And Dissolved" - not Active.
  • Last balance sheet is for Mar 2021 - filings overdue.
  • Litigation present in 1 court forum(s).
  • 2 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
RUBY SHAH 01234567 Director 01/04/2018 6 yrs Approved
VIRAL SHAH 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 75 · Distress 55
Growth signals & trust indicators
Steady revenue growth: +38% over 4 year(s).
Profit expanded 1.42 year-on-year.
Net margin improved to 2.1x.
Operating for 11+ years.
Active GST registration(s).
Distress signals & risk flags
Statutory filings appear overdue.
Adverse company status: Converted To Cmp And Dissolved.
Compliance score is weak (23/100).
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence44/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment62/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view72/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 12 events
07 Jul 2021
Charge satisfied
Hdfc Bank Limited
01 Apr 2021
Director appointed
RUBY SHAH (Designated Partner)
Director appointed
VIRAL SHAH (Designated Partner)
Director ceased
RAJINDER KUMAR AGGARWAL
Director ceased
ANOOP GUPTA
Director ceased
VIRAL SHAH
31 Mar 2021
Director ceased
RAM GOPAL ARORA
Director ceased
RUBY SHAH
Last AGM held
Annual general meeting
Latest balance sheet
Filed with ROC
18 Dec 2018
Charge created
Hdfc Bank Limited - 15.00 cr
13 Mar 2015
Incorporated
Registered with Roc Chandigarh
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
2 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
All 1 registered charge(s) stand satisfied - past borrowings repaid.
Carries an external credit rating of B+ from Crisil.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Jay Formulations Ltd U17119GJ1988PLC010855 Ahmedabad, Gujarat, India
Elysium Pharmaceuticals U24231GJ1995PLC024164 Vadodara, Gujarat, India
East India Pharmaceutical Works U24231WB1936PLC008598 Kolkata, West Bengal, India
Infutec Healthcare U24230MH2005PLC155962 Mumbai, Maharashtra, India
Dr. Willmar Schwabe India U74899DL1994PTC057707 New Delhi, Delhi, India
Batra Brewries And Disttilleries Private Limited U74899CH1986PTC041514 Chandigarh, Chandigarh, India
Maneeshpharma U24230MH1985PLC036952 Mumbai, Maharashtra, India
Rachempharma U24110TG1996PLC022816 Hyderabad, Telangana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Acme Generics before audits and certifications: compliance score 23/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Acme Generics: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 75/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 75/100, margin trends, ownership structure and peer set for Acme Generics - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 62/100, distress signals and MSME payment-delay disclosures - know whether Acme Generics pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Acme Generics - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Acme Generics an active company?

Acme Generics has MCA status “Converted To Cmp And Dissolved” with a compliance score of 23/100 (Caution Indicated).

Is Acme Generics financially healthy?

Acme Generics has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.

Should I do business with Acme Generics?

Its overall Trust Score is 62/100 (Moderate). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Acme Generics?

See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.

Does Acme Generics have loans or charges against its assets?

No open charges - all 1 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Acme Generics up to date with its ROC filings?

Last balance sheet is for Mar 2021 - filings overdue. Overall compliance score: 23/100 (Caution Indicated).

Is it risky to lend to Acme Generics?

Its Credit Risk Score is 75/100 (Low Risk). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.